 FRANKFURT (Reuters) - Investors in Germany's Bayer will get  one share in chemicals and polymers spin-off Lanxess for every  10 Bayer shares held, a German newspaper said, valuing Lanxess  at nearly 1.6 billion euros (\$1.97 billion).